SCHEMBL10150558

SCHEMBL10150558

C=CCOP1(=S)OC[C@H]2O[C@@H](N3C=CC(N)=NC3=C)CC2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16158833 0.81 KMT2A (0.35) —
SCHEMBL13020467 0.60 — —
SCHEMBL16436141 0.57 ALB (0.32) —
SCHEMBL15369632 0.57 ALB (0.46) —
SCHEMBL18720669 0.56 RXFP1 (0.41) —
SCHEMBL17232084 0.55 — —
SCHEMBL16000608 0.52 — —
SCHEMBL14768699 0.52 PDE4D (0.46) —
SCHEMBL10324251 0.52 PDE4D (0.46) —
SCHEMBL17232080 0.52 POLA1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170002037-A1 CYCLIC NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. 2017-01-05 — — US disclosed
US-8772474-B2 Cyclic nucleotide analogs ALIOS BIOPHARMA, INC. (US) 2014-07-08 — — US disclosed
US-20120165286-A1 CYCLIC NUCLEOTIDE ANALOGS ALIOS BIOPHARMA, INC. (US) 2012-06-28 — — US disclosed
Send feedback